|
N03
|
Antiepileptics
|
6
|
10
|
|
N05
|
Psycholeptics
|
3
|
7
|
|
N06
|
Psychoanaleptic
|
1
|
3
|
|
C05
|
Vasoprotectives
|
1
|
1
|
|
C07
|
Beta blocking agents
|
1
|
3
|
|
C08
|
Calcium channel blockers
|
2
|
6
|
|
C09
|
Agents acting on the renin–angiotensin system
|
4
|
26
|
|
C10
|
Serum lipid reducing agents
|
2
|
29
|
|
J01
|
Antibacterial for systemic use
|
10
|
29
|
|
J05
|
Antivirals
|
1
|
1
|
|
B01
|
Antithrombotic agents
|
2
|
15
|
|
M01
|
Anti-inflammatory and antirheumatic products
|
3
|
13
|
|
M05
|
Drugs for treatment of bone diseases
|
1
|
1
|
|
A02
|
Drugs for acid related disorders
|
4
|
14
|
|
A03
|
Drugs for functional gastrointestinal disorders
|
1
|
5
|
|
A10
|
Drugs used in diabetes
|
6
|
39
|
|
H02
|
Corticosteroids for systemic use
|
1
|
3
|
|
H03
|
Thyroid therapy
|
1
|
1
|
|
R03
|
Drugs for obstructive airway disease
|
1
|
6
|
|
G04
|
Urologicals
|
1
|
3
|
|
P02
|
Anthelmintics
|
1
|
1
|
|
Total
|
53
|
216
|
